AI assistant
Hyperfine, Inc. — Director's Dealing 2022
Nov 1, 2022
34088_dirs_2022-11-01_a8d8b821-99f3-4d97-a5ad-97cbb9f68c30.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Hyperfine, Inc. (HYPR)
CIK: 0001833769
Period of Report: 2022-10-31
Reporting Person: Paykel Neela (Gen Counsel & Corp Secretary)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-10-31 | Stock Option (right to buy) | $3.90 | D | 71750 | Disposed | 2032-02-09 | Class A Common Stock (71750) | Direct |
| 2022-10-31 | Stock Option (right to buy) | $0.91 | A | 71750 | Acquired | 2032-02-09 | Class A Common Stock (71750) | Direct |
| 2022-10-31 | Stock Option (right to buy) | $3.90 | D | 85000 | Disposed | 2032-02-09 | Class A Common Stock (85000) | Direct |
| 2022-10-31 | Stock Option (right to buy) | $0.91 | A | 85000 | Acquired | 2032-02-09 | Class A Common Stock (85000) | Direct |
| 2022-10-31 | Stock Option (right to buy) | $3.27 | D | 98250 | Disposed | 2031-04-27 | Class A Common Stock (98250) | Direct |
| 2022-10-31 | Stock Option (right to buy) | $0.91 | A | 98250 | Acquired | 2031-04-27 | Class A Common Stock (98250) | Direct |
Footnotes
F1: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 9, 2022, of which 25,411 shares vested and the remainder of the options vesting in equal monthly installments, subject to Ms. Paykel's continued service on each vesting date.
F2: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The shares underlying this option vest as to 25% on February 9, 2023, and 2.083% at the end of each month thereafter beginning on March 31, 2023, subject to Ms. Paykel's continued service through the applicable vesting date.
F3: The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 30,702 shares vested and the remainder of the options vesting in equal monthly installments, subject to Ms. Paykel's continued service on each vesting date.